Cargando…
Loading, please waitCargando…
Loading, please waitMonthly editorial
Monthly updates from Dr. Claudia Labastida and our medical team — written for patients, families, and clinicians who want measured, evidence-aware information on regenerative medicine.
What you'll receive
A short editorial on one or two newly published studies in stem cell biology, regenerative orthopedics, or longevity medicine. We highlight what the data actually shows — not the press release.
When new evidence emerges for a condition we treat (knee osteoarthritis, chronic back pain, autoimmune protocols, post-COVID recovery, andropause), we summarize what changed and what it means for candidacy and expectations.
Anonymized, consent-cleared follow-ups from patients who agreed to share their trajectory. We publish the wins and the partial responses honestly, never as marketing.
Plain-language summaries of relevant COFEPRIS guidance, NOM updates, and cross-border regulatory developments (FDA, EMA) that affect what we can and cannot offer.
Frequency
One email per month, sent on the second Wednesday. No automated sequences, no abandoned-cart nudges, no upsell flows. If a month is quiet on the editorial side, we skip it rather than fill space.
Sample issue
Our most-read article in 2026 lays out the week-by-week timeline most patients experience after a mesenchymal stem cell infusion. It is a good representative of the tone and depth of the newsletter — careful, specific, and willing to discuss what does NOT typically happen at each stage.
Privacy promise
Recent articles
Each issue references the editorial calendar on our blog. Here are four recent posts that show the kind of writing you can expect in your inbox.
Prefer to talk to a person?
If you have a specific case in mind and want a physician's read before deciding whether the newsletter is enough, you can book a no-cost virtual consultation directly. The newsletter is informational — the consultation is clinical.